CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY - USD ($) shares in Thousands, $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Deferred Compensation	Retained Earnings (Deficit)	Retained Earnings (Deficit) Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (Loss)	Treasury Stock
Beginning balance (in shares) at Feb. 02, 2019			15,873						(47)
Beginning balance at Feb. 02, 2019	$ 314,437	$ (1,667)	$ 1,588	$ 146,991	$ 2,685	$ 180,792	$ (1,667)	$ (14,934)	$ (2,685)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of stock awards (in shares)			480
Vesting of stock awards	42		$ 47	(5)
Stock-based compensation expense	16,219			16,219
Purchase and retirement of shares (in shares)			(1,591)
Purchase and retirement of common stock	(133,605)		$ (159)	(25,439)		(108,007)
Dividends declared ($2.24 per share)	(34,928)					(34,928)
Unvested dividends	0			1,275		(1,275)
Change in cumulative translation adjustment	1,388							1,388
Change in fair value of cash flow hedges, net of income taxes	1							1
Deferral of common stock into deferred compensation plan	0				271				$ (271)
Deferral of common stock into deferred compensation plan (in shares)									(4)
Net income (loss)	73,300					73,300
Ending balance (in shares) at Feb. 01, 2020			14,762						(51)
Ending balance at Feb. 01, 2020	$ 235,187		$ 1,476	139,041	2,956	108,215		(13,545)	$ (2,956)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]	Accounting Standards Update 2016-02 [Member]
Vesting of stock awards (in shares)			173
Vesting of stock awards	$ 0		$ 17	(17)
Stock-based compensation expense	14,316			14,316
Purchase and retirement of shares (in shares)			(294)
Purchase and retirement of common stock	(15,490)		$ (29)	(4,821)		(10,640)
Change in cumulative translation adjustment	477
Other comprehensive loss	(271)							(271)
Change in fair value of cash flow hedges, net of income taxes	(748)
Deferral of common stock into deferred compensation plan	0				209				$ (209)
Deferral of common stock into deferred compensation plan (in shares)									(6)
Net income (loss)	(140,365)					(140,365)
Ending balance (in shares) at Jan. 30, 2021			14,641						(57)
Ending balance at Jan. 30, 2021	93,377		$ 1,464	148,519	3,165	(42,790)		(13,816)	$ (3,165)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of stock awards (in shares)			348
Vesting of stock awards	0		$ 35	(35)
Stock-based compensation expense	30,942			30,942
Purchase and retirement of shares (in shares)			(1,025)
Purchase and retirement of common stock	(85,648)		$ (103)	(19,078)		(66,467)
Change in cumulative translation adjustment	(370)
Other comprehensive loss	(370)							(370)
Change in fair value of cash flow hedges, net of income taxes	0
Deferral of common stock into deferred compensation plan	0				278				$ (278)
Deferral of common stock into deferred compensation plan (in shares)									(4)
Net income (loss)	187,171					187,171
Ending balance (in shares) at Jan. 29, 2022			13,964						(61)
Ending balance at Jan. 29, 2022	$ 225,472		$ 1,396	$ 160,348	$ 3,443	$ 77,914		$ (14,186)	$ (3,443)